Trial intelligence / Profile preview

Iloprost for Pulmonary Oxygenation in Obese Patients During One-lung Ventilation

NCT04583046Completed

Sponsor
Yonsei University
Start
Nov 2020
Primary completion
Sep 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial in hypoxemia comparing Iloprost Group with Placebo Group (2 arms). Primary endpoints: Partial Pressure of Oxygen, PaO2/FiO2 ratio and 1 more. Started Nov 2020; status: completed.

02

Drugs

iloprost
03

Conditions

hypoxemia

Beyond the preview

Go deeper on NCT04583046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04583046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call